Latest & greatest articles for preeclampsia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on preeclampsia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on preeclampsia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for preeclampsia

1. Gestational Hypertension and Preeclampsia

Gestational Hypertension and Preeclampsia Sign In (ACOG) Sign in to your ACOG account Email is required. Please enter valid Email. was not found in our system. Would you like to associated with your account? Forgot your email address? JSOG Member? © 2019 - American College of Obstetricians and Gynecologists

American College of Obstetricians and Gynecologists2019

2. Torsemide for Prevention of Persistent Postpartum Hypertension in Women With Preeclampsia: A Randomized Controlled Trial

Torsemide for Prevention of Persistent Postpartum Hypertension in Women With Preeclampsia: A Randomized Controlled Trial 30303905 2018 10 10 1873-233X 2018 Oct 05 Obstetrics and gynecology Obstet Gynecol Torsemide for Prevention of Persistent Postpartum Hypertension in Women With Preeclampsia: A Randomized Controlled Trial. 10.1097/AOG.0000000000002941 To evaluate whether torsemide reduces the rate of persistent postpartum hypertension in women with preeclampsia. We conducted a randomized (...) , double-blind, placebo-controlled trial of women with preeclampsia at a tertiary center from August 2016 to September 2017. Those with gestational hypertension or renal or cardiopulmonary failure were excluded. Within 24 hours of delivery, women were randomized one to one to oral torsemide, 20 mg/d, or placebo, for 5 days. Our primary outcome was blood pressure greater than or equal to 150 mm Hg systolic or 100 mm Hg diastolic (or both) on two occasions at least 4 hours apart by postpartum day 5

EvidenceUpdates2018

3. Esomeprazole to treat women with preterm preeclampsia: a randomized placebo controlled trial

Esomeprazole to treat women with preterm preeclampsia: a randomized placebo controlled trial 30055127 2018 10 01 1097-6868 219 4 2018 Oct American journal of obstetrics and gynecology Am. J. Obstet. Gynecol. Esomeprazole to treat women with preterm preeclampsia: a randomized placebo controlled trial. 388.e1-388.e17 S0002-9378(18)30606-9 10.1016/j.ajog.2018.07.019 Preterm preeclampsia has a high rate of fetal death or disability. There is no treatment to slow the disease, except delivery (...) . Preclinical studies have identified proton pump inhibitors as a possible treatment. The purpose of this study was to examine whether esomeprazole could prolong pregnancy in women who have received a diagnosis of preterm preeclampsia. We performed a double-blind, randomized controlled trial at Tygerberg Hospital in South Africa. Women with preterm preeclampsia (gestational age 26 weeks+0 days to 31 weeks+6 days) were assigned randomly to 40-mg daily esomeprazole or placebo. The primary outcome

EvidenceUpdates2018

4. Preeclampsia

Preeclampsia Top results for preeclampsia - Trip Database or use your Google+ account Find evidence fast My query is: English Français Deutsch Čeština Español Magyar Svenska ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing (...) the search button. An example search might look like (#1 or #2) and (#3 or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for preeclampsia The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines

Trip Latest and Greatest2018

5. Effect of ibuprofen vs acetaminophen on postpartum hypertension in preeclampsia with severe features: a double-masked, randomized controlled trial

Effect of ibuprofen vs acetaminophen on postpartum hypertension in preeclampsia with severe features: a double-masked, randomized controlled trial 29505772 2018 05 25 1097-6868 218 6 2018 Jun American journal of obstetrics and gynecology Am. J. Obstet. Gynecol. Effect of ibuprofen vs acetaminophen on postpartum hypertension in preeclampsia with severe features: a double-masked, randomized controlled trial. 616.e1-616.e8 S0002-9378(18)30175-3 10.1016/j.ajog.2018.02.016 (...) Nonsteroidal antiinflammatory drug use has been shown to increase blood pressure in nonpregnant adults. Because of this, the American College of Obstetricians and Gynecologists suggests avoiding their use in women with postpartum hypertension; however, evidence to support this recommendation is lacking. Our goal was to test the hypothesis that nonsteroidal antiinflammatory drugs, such as ibuprofen, adversely affect postpartum blood pressure control in women with preeclampsia with severe features. At delivery, we randomized

EvidenceUpdates2018

6. Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit

Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit 29505771 2018 05 25 1097-6868 218 6 2018 Jun American journal of obstetrics and gynecology Am. J. Obstet. Gynecol. Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit. 612.e1-612.e6 S0002-9378(18)30173-X 10.1016/j.ajog.2018.02.014 Preeclampsia is a major pregnancy complication with adverse (...) short- and long-term implications for both the mother and baby. Screening for preeclampsia at 11-13 weeks' gestation by a combination of maternal demographic characteristics and medical history with measurements of biomarkers can identify about 75% of women who develop preterm preeclampsia with delivery at <37 weeks' gestation and 90% of those with early preeclampsia at <32 weeks, at a screen-positive rate of 10%. A recent trial (Combined Multimarker Screening and Randomized Patient Treatment

EvidenceUpdates2018

7. Use of Antihypertensive Drugs During Preeclampsia

Use of Antihypertensive Drugs During Preeclampsia 29896480 2018 11 14 2297-055X 5 2018 Frontiers in cardiovascular medicine Front Cardiovasc Med Use of Antihypertensive Drugs During Preeclampsia. 50 10.3389/fcvm.2018.00050 Treatment of pregnancy-related hypertensive disorders, such as preeclampsia (PE), remain a challenging problem in obstetrics. Typically, aggressive antihypertensive drug treatment options are avoided to prevent pharmacological-induced hypotension. Another major concern (...) Medical Center-Temple, Texas A&M Health Science Center, Temple, TX, United States. eng Journal Article 2018 05 29 Switzerland Front Cardiovasc Med 101653388 2297-055X antihypertensive drugs cardiovascular hypertension preeclampsia pregnancy 2018 02 14 2018 05 04 2018 6 14 6 0 2018 6 14 6 0 2018 6 14 6 1 epublish 29896480 10.3389/fcvm.2018.00050 364135 PMC5987086 Cochrane Database Syst Rev. 2003;(4):CD000128 14583911 Cochrane Database Syst Rev. 2003;(4):CD000127 14583910 Acta Med Iran. 2011;49(11):701

Frontiers in cardiovascular medicine2018 Full Text: Link to full Text with Trip Pro

8. Meta-analysis on the effect of aspirin use for prevention of preeclampsia on placental abruption and antepartum hemorrhage

Meta-analysis on the effect of aspirin use for prevention of preeclampsia on placental abruption and antepartum hemorrhage 29305829 2018 04 24 1097-6868 218 5 2018 May American journal of obstetrics and gynecology Am. J. Obstet. Gynecol. Meta-analysis on the effect of aspirin use for prevention of preeclampsia on placental abruption and antepartum hemorrhage. 483-489 S0002-9378(17)32812-0 10.1016/j.ajog.2017.12.238 Impaired placentation in the first 16 weeks of pregnancy is associated (...) with increased risk of subsequent development of preeclampsia, birth of small-for-gestational-age neonates, and placental abruption. Previous studies reported that prophylactic use of aspirin reduces the risk of preeclampsia and small-for-gestational-age neonates with no significant effect on placental abruption. However, meta-analyses of randomized controlled trials that examined the effect of aspirin in relation to gestational age at onset of therapy and dosage of the drug reported that significant

EvidenceUpdates2018

9. A study of the diagnostic value of Inhibin A Tests for occurrence of preeclampsia in pregnant women

A study of the diagnostic value of Inhibin A Tests for occurrence of preeclampsia in pregnant women Electronic Physician (ISSN: 2008-5842) http://www.ephysician.ir January 2018, Volume: 10, Issue: 1, Pages: 6186-6192, DOI: http://dx.doi.org/10.19082/6186 Corresponding author: Associate Professor Dr. Farzaneh Broumand, Urmia University of Medical Sciences, Urmia, Iran. Tel: +98.9143412320, Fax: +98.4433197656, Emal:farzaneh.bbb222@gmail.com Received: August 27, 2017, Accepted: October 30, 2017 (...) 6286 A study of the diagnostic value of Inhibin A Tests for occurrence of preeclampsia in pregnant women Farzaneh Broumand 1 , Shaker Salari Lak 2 , Farhad Nemati 3 , Atefeh Mazidi 4 1 M.D., Associate Professor of Gynecology, Urmia University of Medical Sciences, Urmia, Iran 2 Associate Professor of Epidemiology, Department of Public Health, Tabriz Branch, Islamic Azad University, Tabriz, Iran 3 M.D., Cytopathologist, Nemati Clinical Laboratory, Urmia, Iran 4 M.D., Gynecologist, Urmia University

Electronic physician2018 Full Text: Link to full Text with Trip Pro

10. Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history

Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history 28784417 2017 11 16 2018 01 11 1097-6868 217 5 2017 11 American journal of obstetrics and gynecology Am. J. Obstet. Gynecol. Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according (...) to their characteristics and medical and obstetrical history. 585.e1-585.e5 S0002-9378(17)30929-8 10.1016/j.ajog.2017.07.038 The Combined Multimarker Screening and Randomized Patient Treatment with Aspirin for Evidence-Based Preeclampsia Prevention trial demonstrated that in women who were at high risk for preterm preeclampsia with delivery at <37 weeks' gestation identified by screening by means of an algorithm that combines maternal factors and biomarkers at 11-13 weeks' gestation, aspirin administration from 11

EvidenceUpdates2018

11. Association between insulin resistance and preeclampsia in obese non-diabetic women receiving metformin

Association between insulin resistance and preeclampsia in obese non-diabetic women receiving metformin 29225676 2018 11 13 1753-495X 10 4 2017 Dec Obstetric medicine Obstet Med Association between insulin resistance and preeclampsia in obese non-diabetic women receiving metformin. 170-173 10.1177/1753495X17725465 To examine whether the reduced incidence of preeclampsia in non-diabetic obese pregnant women treated with metformin is mediated by changes in insulin resistance. This was a secondary (...) analysis of obese pregnant women in a randomised trial (MOP trial). Fasting plasma glucose and insulin were measured in 384 of the 400 women who participated in the MOP trial. Homeostasis model assessment of insulin resistance (HOMA-IR) was compared in the metformin and placebo groups and in those that developed preeclampsia versus those that did not develop preeclampsia. At 28 weeks, median HOMA-IR was significantly lower in the metformin group. Logistic regression analysis demonstrated

Obstetric medicine2017 Full Text: Link to full Text with Trip Pro

12. MicroRNAs: New Players in the Pathobiology of Preeclampsia

MicroRNAs: New Players in the Pathobiology of Preeclampsia 28993808 2018 11 13 2297-055X 4 2017 Frontiers in cardiovascular medicine Front Cardiovasc Med MicroRNAs: New Players in the Pathobiology of Preeclampsia. 60 10.3389/fcvm.2017.00060 Our understanding of how microRNAs (miRNAs) regulate gene networks and affect different molecular pathways leading to various human pathologies has significantly improved over the years. In contrary, the role of miRNAs in pregnancy-related hypertensive (...) disorders such as preeclampsia (PE) is only beginning to emerge. Recent papers highlight that adverse pregnancy outcomes are associated with aberrant expression of several miRNAs. Presently, efforts are underway to determine the biologic function of these placental miRNAs which can shed light on their contribution to these pregnancy-related disease conditions. The discovery that miRNAs are stable in circulation coupled with the fact that the placenta is capable of releasing them to the circulation

Frontiers in cardiovascular medicine2017 Full Text: Link to full Text with Trip Pro

13. The Impact of Silymarin on Improvement of Hepatic Abnormalities in Patients with Severe Preeclampsia: A Randomized Clinical Trial

The Impact of Silymarin on Improvement of Hepatic Abnormalities in Patients with Severe Preeclampsia: A Randomized Clinical Trial 28979748 2018 11 13 2008-5842 9 8 2017 Aug Electronic physician Electron Physician The Impact of Silymarin on Improvement of Hepatic Abnormalities in Patients with Severe Preeclampsia: A Randomized Clinical Trial. 5098-5106 10.19082/5098 Preeclampsia is a pregnancy-specific disorder, associated with increased blood pressure and proteinuria, and in extreme cases (...) it can also cause liver and kidney problems. To determine the impact of silymarin on the improvement of severe preeclampsia. This randomized clinical trial was conducted at Hajar Hospital in Shahrekord, Iran, from April 2014 to September 2015. Sixty patients whose pregnancy had ended as a result of severe preeclampsia, were entered into the study. Patients were randomly divided into two groups of thirty study and control groups. In addition to current treatment for preeclampsia, case groups were

Electronic physician2017 Full Text: Link to full Text with Trip Pro

14. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.

Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. Background Preterm preeclampsia is an important cause of maternal and perinatal death and complications. It is uncertain whether the intake of low-dose aspirin during pregnancy reduces the risk of preterm preeclampsia. Methods In this multicenter, double-blind, placebo-controlled trial, we randomly assigned 1776 women with singleton pregnancies who were at high risk for preterm preeclampsia to receive aspirin, at (...) a dose of 150 mg per day, or placebo from 11 to 14 weeks of gestation until 36 weeks of gestation. The primary outcome was delivery with preeclampsia before 37 weeks of gestation. The analysis was performed according to the intention-to-treat principle. Results A total of 152 women withdrew consent during the trial, and 4 were lost to follow up, which left 798 participants in the aspirin group and 822 in the placebo group. Preterm preeclampsia occurred in 13 participants (1.6%) in the aspirin group

NEJM2017

15. Frontal lobe meningioma mimicking preeclampsia: A case study

Frontal lobe meningioma mimicking preeclampsia: A case study 29225682 2018 12 01 1753-495X 10 4 2017 Dec Obstetric medicine Obstet Med Frontal lobe meningioma mimicking preeclampsia: A case study. 192-194 10.1177/1753495X17701847 We report a case of a left frontal lobe meningioma presenting in a woman with proteinuric preeclampsia in her first term pregnancy. The patient had a background of antepartum migraines that resolved in the second trimester of pregnancy. Postpartum, she required urgent (...) surgery and sustained convulsions after surgery. She had no residual disease and has had another successful pregnancy. This case highlights the importance of cerebral imaging in the context of an atypical clinical course of preeclampsia. Although headaches are common in pregnancy and usually benign, other, more serious, diagnoses should be considered with atypical headaches, a change in the nature of the headache, and headaches that persist despite appropriate treatment. A full neurological

Obstetric medicine2017 Full Text: Link to full Text with Trip Pro

16. Screening for Preeclampsia: US Preventive Services Task Force Recommendation Statement.

Screening for Preeclampsia: US Preventive Services Task Force Recommendation Statement. Importance: Preeclampsia affects approximately 4% of pregnancies in the United States. It is the second leading cause of maternal mortality worldwide and may lead to serious maternal complications, including stroke, eclampsia, and organ failure. Adverse perinatal outcomes for the fetus and newborn include intrauterine growth restriction, low birth weight, and stillbirth. Many of the complications associated (...) with preeclampsia lead to early induction of labor or cesarean delivery and subsequent preterm birth. Subpopulation Considerations: Preeclampsia is more prevalent among African American women than among white women. Differences in prevalence may be, in part, due to African American women being disproportionally affected by risk factors for preeclampsia. African American women also have case fatality rates related to preeclampsia 3 times higher than rates among white women. Inequalities in access to adequate

JAMA2017

17. Antiplatelet therapy before or after 16 weeks' gestation for preventing preeclampsia: an individual participant data meta-analysis

Antiplatelet therapy before or after 16 weeks' gestation for preventing preeclampsia: an individual participant data meta-analysis 27810551 2016 11 04 2017 02 02 1097-6868 216 2 2017 Feb American journal of obstetrics and gynecology Am. J. Obstet. Gynecol. Antiplatelet therapy before or after 16 weeks' gestation for preventing preeclampsia: an individual participant data meta-analysis. 121-128.e2 S0002-9378(16)30911-5 10.1016/j.ajog.2016.10.016 The optimum time for commencing antiplatelet (...) therapy for the prevention of preeclampsia and its complications is unclear. Aggregate data meta-analyses suggest that aspirin is more effective if given prior to 16 weeks' gestation, but data are limited because of an inability to place women in the correct gestational age subgroup from relevant trials. The objective of the study was to use the large existing individual participant data set from the Perinatal Antiplatelet Review of International Studies Collaboration to assess whether the treatment

EvidenceUpdates2017

18. Preeclampsia: Screening

Preeclampsia: Screening Final Recommendation Statement: Preeclampsia: Screening - US Preventive Services Task Force Search USPSTF Website Text size: Assembly version: 1.0.0.308 Last Build: 3/6/2018 4:20:40 PM You are here: Final Recommendation Statement : Final Recommendation Statement Final Recommendation Statement Preeclampsia: Screening Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare (...) Research and Quality or the U.S. Department of Health and Human Services. Recommendation Summary Population Recommendation Grade Pregnant woman The USPSTF recommends screening for preeclampsia in pregnant women with blood pressure measurements throughout pregnancy. To read the recommendation statement in JAMA , select . To read the evidence summary in JAMA , select . Table of Contents Preface The US Preventive Services Task Force (USPSTF) makes recommendations about the effectiveness of specific

U.S. Preventive Services Task Force2017

19. Final recommendation statement: preeclampsia: screening.

Final recommendation statement: preeclampsia: screening. Final recommendation statement: preeclampsia: screening. | National Guideline Clearinghouse success fail JUN 09 2017 2018 2019 03 Oct 2017 - 12 Jul 2018 COLLECTED BY Organization: Formed in 2009, the Archive Team (not to be confused with the archive.org Archive-It Team) is a rogue archivist collective dedicated to saving copies of rapidly dying or deleted websites for the sake of history and digital heritage. The group is 100% composed (...) In Username or Email * Password * Remember Me Don't have an account? The AHRQ National Guideline Clearinghouse (NGC, guideline.gov) Web site will not be available after July 16, 2018 because federal funding through AHRQ will no longer be available to support the NGC as of that date. For additional information, read our . Guideline Summary NGC:011201 2017 Apr NEATS Assessment Final recommendation statement: preeclampsia: screening. Final recommendation statement: preeclampsia: screening. [internet

National Guideline Clearinghouse (partial archive)2017

20. The Relationship Between Blood Lead Level and Preeclampsia

The Relationship Between Blood Lead Level and Preeclampsia 28163864 2018 11 13 2008-5842 8 12 2016 Dec Electronic physician Electron Physician The Relationship Between Blood Lead Level and Preeclampsia. 3450-3455 10.19082/3450 Lead is a heavy metal to which people are commonly exposed. One of the possible mechanisms of tissue damages caused by this toxic metal is oxidative stress, which in turn may cause numerous pregnancy complications such as preeclampsia. The present study was conducted (...) to determine the relationship between maternal Blood Lead Level (BLL) and preeclampsia. The present case-control study was conducted on 158 pregnant women admitted to a hospital in Zanjan, Iran, from August 2015 to March 2016. To measure their BLL, 1.5 cc of blood was drawn from each participant. The demographic and obstetric details of the patients were recorded in a form. The potentiometric method was used to test the samples. The data obtained were analyzed by SPSS version 22, using Mann-Whitney U test

Electronic physician2016 Full Text: Link to full Text with Trip Pro